|
|
|
Insider
Information: |
Gage L Patrick |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
123,884 |
|
Indirect Shares
|
1,850 |
|
|
Direct
Value |
$1,645,562 |
|
|
Indirect Value
|
$89,744 |
|
|
Total
Shares |
125,734 |
|
|
Total
Value |
$1,735,306 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
Percentage
Gain/Loss : |
0.0%
|
184.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PDL Biopharma Inc |
PDLI |
Interim CEO, Director |
2008-04-28 |
19,555 |
2004-05-24 |
0 |
Premium* |
|
Neose Technologies Inc |
NTEC |
Director |
2009-01-27 |
75,397 |
2005-05-05 |
0 |
Premium* |
|
Cytokinetics Inc |
CYTK |
Director |
2021-11-08 |
28,932 |
2021-11-08 |
1,850 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2020-07-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,944) |
0 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2020-07-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(191) |
0 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2014-05-09 |
4 |
B |
$4.10 |
$3,485 |
I/I |
850 |
850 |
2.1 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-05-28 |
4 |
B |
$10.70 |
$9,095 |
I/I |
850 |
850 |
2.1 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-06-04 |
4 |
B |
$10.05 |
$5,025 |
I/I |
500 |
1,350 |
2.1 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2015-08-31 |
4 |
B |
$6.95 |
$6,950 |
I/I |
1,000 |
1,850 |
2.1 |
- |
|
PDLI |
PDL Biopharma Inc |
Director |
|
2004-05-24 |
4 |
B |
$19.00 |
$38,078 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-06-05 |
4 |
B |
$10.28 |
$10,027 |
I/I |
975 |
2,325 |
2.1 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-06-13 |
4 |
B |
$11.42 |
$5,710 |
I/I |
500 |
2,825 |
2.1 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2017-03-15 |
4 |
B |
$7.47 |
$7,470 |
I/I |
1,000 |
3,825 |
2.1 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2014-05-14 |
4 |
B |
$9.25 |
$46,249 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2015-08-12 |
4 |
S |
$45.00 |
$675,000 |
D/D |
(15,000) |
5,000 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
Director |
|
2005-05-05 |
4 |
B |
$18.04 |
$100,242 |
D/D |
5,555 |
7,555 |
2.39 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2014-05-09 |
4 |
B |
$4.09 |
$40,892 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
NTEC |
Neose Technologies Inc |
Director |
|
2005-05-05 |
4 |
B |
$2.78 |
$25,573 |
D/D |
9,200 |
12,700 |
2.39 |
- |
|
PDLI |
PDL Biopharma Inc |
Interim CEO |
|
2008-04-28 |
4 |
OE |
$7.01 |
$84,120 |
D/D |
12,000 |
19,555 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2015-05-06 |
4 |
B |
$5.69 |
$57,124 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2015-08-12 |
4 |
OE |
$7.07 |
$106,050 |
D/D |
15,000 |
20,000 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-03-06 |
4 |
S |
$14.82 |
$118,592 |
D/D |
(8,000) |
20,000 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-05-18 |
4 |
D |
$22.22 |
$56,194 |
D/D |
(2,529) |
20,804 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-12-15 |
4 |
S |
$21.00 |
$162,038 |
D/D |
(7,716) |
20,804 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
Director |
|
2021-01-04 |
4 |
A |
$19.56 |
$18,738 |
D/D |
958 |
21,762 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2021-03-12 |
4 |
S |
$21.22 |
$219,372 |
D/D |
(10,339) |
21,762 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
Director |
|
2021-03-19 |
4 |
S |
$24.45 |
$244,468 |
D/D |
(10,000) |
21,762 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-05-18 |
4 |
OE |
$16.86 |
$56,194 |
D/D |
3,333 |
23,333 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|